6615.TWO Sofiva Genomics Co.,Ltd.

Healthcare Diagnostics & Research Taiwan OTC Exchange
32.80 TWD
Close of Nov 6, 2026
28.90 40.00
Market cap
TWD 708M
P/E
49.7x
P/B
1.09x
ROE
6.2%
Dividend yield
0.91%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 6615.TWO undervalued?

Graham number
Price32.80
Graham value21.16
Premium55.0%

6615.TWO trades 55.0% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Sofiva Genomics Co.,Ltd. fundamental analysis

No fundamental analysis for Sofiva Genomics Co.,Ltd. yet.

Sofiva Genomics Co.,Ltd. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Sofiva Genomics Co.,Ltd.

Sofiva Genomics Co.,Ltd. provides pre-pregnancy, prenatal, and newborn genetic testing and medical testing services in Taiwan and internationally. The company offers reproductive testing services, including preimplantation genetic testing for aneuploidy (PGT-A), non-invasive preimplantation genetic testing for aneuploidy (niPGT-A), and preimplantation genetic testing for monogenic diseases (PGT-M); and prenatal testing services, such as non-invasive prenatal screening, array…

Full company profile